Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 41Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 32EVOFEM INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SECNIDAZOLE

US Patent Number : 10335390

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209363

Patent Use Code : U-2583

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-04

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SECNIDAZOLE

US Patent Number : 11000507

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209363

Patent Use Code : U-3302

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-04

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SECNIDAZOLE

US Patent Number : 11000507

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209363

Patent Use Code : U-3270

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-04

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SECNIDAZOLE

US Patent Number : 11020377

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209363

Patent Use Code : U-3302

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-04

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SECNIDAZOLE

US Patent Number : 11020377

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209363

Patent Use Code : U-3270

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-04

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SECNIDAZOLE

US Patent Number : 11000508

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209363

Patent Use Code : U-3302

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-04

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SECNIDAZOLE

US Patent Number : 11000508

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209363

Patent Use Code : U-3270

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-04

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SECNIDAZOLE

US Patent Number : 10682338

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209363

Patent Use Code : U-3270

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-04

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SECNIDAZOLE

US Patent Number : 10849884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209363

Patent Use Code : U-3270

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-04

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SECNIDAZOLE

US Patent Number : 10849884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209363

Patent Use Code : U-3302

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-04

blank